BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22381622)

  • 1. YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
    Hwang TL; Tang MC; Kuo LM; Chang WD; Chung PJ; Chang YW; Fang YC
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):193-200. PubMed ID: 22381622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
    Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
    Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.
    Lu DY; Tang CH; Liou HC; Teng CM; Jeng KC; Kuo SC; Lee FY; Fu WM
    Br J Pharmacol; 2007 Jun; 151(3):396-405. PubMed ID: 17401444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
    Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
    Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2.
    Chen CC; Chiu KT; Sun YT; Chen WC
    J Biol Chem; 1999 Oct; 274(44):31559-64. PubMed ID: 10531359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC; Garthwaite J
    Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-mediated upregulation of the expression of neuronal NO synthase in human A673 neuroepithelioma cells results in a decrease in the level of bioactive NO production: analysis of the signaling mechanisms that are involved.
    Boissel JP; Bros M; Schröck A; Gödtel-Armbrust U; Förstermann U
    Biochemistry; 2004 Jun; 43(22):7197-206. PubMed ID: 15170357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of tumor necrosis factor-alpha expression by YC-1 in alveolar macrophages through a cyclic GMP-independent pathway.
    Hwang TL; Wu CC; Guh JH; Teng CM
    Biochem Pharmacol; 2003 Jul; 66(1):149-56. PubMed ID: 12818375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.
    Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF
    Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YC-1 attenuates homotypic human neutrophil aggregation through inhibition of phosphodiesterase activity.
    Hwang TL; Zhuo SK; Pan YL
    Eur J Pharmacol; 2008 Jan; 579(1-3):395-402. PubMed ID: 18001706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells.
    Ramos-Espiritu LS; Hess KC; Buck J; Levin LR
    J Pharmacol Exp Ther; 2011 Sep; 338(3):925-31. PubMed ID: 21665942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
    Bidwell P; Joh K; Leaver HA; Rizzo MT
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretory-secretory products from Paragonimus westermani increase nitric oxide production in microglia in PKC-dependent and -independent manners.
    Jin Y; Choi IY; Kim C; Hong S; Kim WK
    Neurosci Res; 2009 Oct; 65(2):141-7. PubMed ID: 19539668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
    Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
    Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
    Dunkern TR; Feurstein D; Rossi GA; Sabatini F; Hatzelmann A
    Eur J Pharmacol; 2007 Oct; 572(1):12-22. PubMed ID: 17659276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
    Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
    Liu XM; Peyton KJ; Mendelev NN; Wang H; Tulis DA; Durante W
    Mol Pharmacol; 2009 Jan; 75(1):208-17. PubMed ID: 18923065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.